- Emergence of Severe Metastatic Hypervirulent Klebsiella ...🔍
- Identification and Characterization of NDM|1|producing ...🔍
- A case of NDM|carbapenemase|producing hypervirulent Klebsiella ...🔍
- Carbapenem|resistant hypervirulent ST23 Klebsiella pneumoniae ...🔍
- The making of hypervirulent Klebsiella pneumoniae🔍
- Detection of carbapenem|resistant hypervirulent Klebsiella ...🔍
- The Rapid Emergence of Hypervirulent Klebsiella Species ...🔍
- Emergence of KPC|2 and NDM|5|coproducing...🔍
Emergence of KPC|2 and NDM|5|coproducing hypervirulent ...
Emergence of Severe Metastatic Hypervirulent Klebsiella ... - medRxiv
Emergence of KPC-producing Klebsiella pneumoniae. 1 hypervirulent clone of capsular serotype K1 that belongs to sequence type 11 in Mainland ...
Identification and Characterization of NDM-1-producing ...
Emergence of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae strains in China. ... Draft genome sequence of an NDM-1- and KPC ...
A case of NDM-carbapenemase-producing hypervirulent Klebsiella ...
The emergence of carbapenemase-producing hypervirulent K. pneumoniae strains ... hypervirulent strains of other capsular types, particularly K2 [2, 3].
Carbapenem-resistant hypervirulent ST23 Klebsiella pneumoniae ...
... producing KPC-2 and VIM-1) (Fig. 2). In 58 of these 61 isolates (95%) the ... Emergence of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae ...
The making of hypervirulent Klebsiella pneumoniae - Dai - 2022
pneumoniae carbapenemases gene (blaKPC), New Delhi metallo-β-lactamase gene (blaNDM), and oxacillinase-48 gene (blaOXA-48). Hypervirulent K.
Detection of carbapenem-resistant hypervirulent Klebsiella ...
Clonal relatedness of eight NDM-1-KPC-2-CR-hvKP strains was analysed by DNA fingerprinting of enterobacterial repeti- tive intergenic consensus ...
The Rapid Emergence of Hypervirulent Klebsiella Species ... - MDPI
Hypervirulent Klebsiella pneumoniae, a 5-Year Study in a French ICU. J ... KPC-2-Producing Klebsiella Pneumonaie Sequence Type 23 from the Americas. J ...
Emergence of KPC-2 and NDM-5-coproducing... - Meditact
The emergence of Klebsiella pneumoniae carbapenemase-2 (KPC-2) and New Delhi metallo-β-lactamase (NDM)-coproducing hypervirulent carbapenem-resistant Klebsiella ...
High prevalence of Neisseria meningitidis hypervirulent lineages ...
Semantic Scholar extracted view of "High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern ...
OUCRU hosts BactiVac Network Meeting to drive global vaccine ...
... hypervirulent Klebsiella pneumoniae in Vietnam ... The natural history and transmission potential of asymptomatic SARS-CoV-2 infection ...
Klebsiella pneumoniae Liver Abscess as a Cause of Lung Entrapment
... 5]. Abscess microbiology has also been shown to impact outcomes [1,4] ... 2 cm subphrenic in segment VIII and a small right pleural ...
Immuron Limited to Present at November 21st Virtual Investor ...
The underlying nature of Immuron's platform technology enables the development of medicines across a large range of infectious diseases. The ...
Clinical Review - General Surgery News
Beginning in 2000, hypervirulent strains of C. difficile have emerged, which ... 2-Minute Drill: Robotic Duodenal-Ileal Anastomosis in SADI · Video.
Immuron Limited to Present at November 21st Virtual Investor ...
In This Article: · About the Investor Summit · About Immuron. Immuron Limited (ASX:IMC, NASDAQ:IMRN), is an Australian biopharmaceutical company ...
Indonesia faces gaps in hospital antibiotic programmes amid fight ...
... hypervirulent Klebsiella pneumoniae in Vietnam ... The natural history and transmission potential of asymptomatic SARS-CoV-2 infection ...
High diversity of strain clonality and metallo-β-lactamases genes ...
... hypervirulent Klebsiella pneumoniae ST11-K64 co-producing NDM-1 and KPC-2 in a tertiary hospital in Wuhan. J Hosp Infect 131:70–80. https ...
Immuron to Present at Q4 Virtual Investor Summit - Stock Titan
Immuron (IMRN) has one commercial product and two pipeline assets in development across three clinical programs for gut mediated diseases. What ...
Immuron Limited to Present at November 21st Virtual Investor ...
... (2) Protection of disease recurrence (67%, P <0.01) and (3) Treatment of ... 5/5/22 8:22:54 PM ET. $IMRN. Biotechnology: Pharmaceutical ...
Immuron Limited to Present at November 21st Virtual Investor Sum
The underlying nature of Immuron's platform technology enables the development of medicines across a large range of infectious diseases. The ...
I 'died' twice after being electrocuted - 4160 volts shot through my brain
... hypervirulent' superbug now found in 16 countries'Rotten apple ... Updated: 2:18, 14 Nov 2024. Click to share on X/Twitter (Opens in new ...